EURAD would like to invite you to participate in an important public consultation launched by the European Commission to gather views on the EU Drugs Strategy and Action Plan.
The European Commission is currently carrying out a mid-term assessment of the EU Drugs Strategy 2013-2020 and EU Action Plan on Drugs 2013-2016 to check how their objectives have been reached so far, which actions have been implemented and with which impact. This public consultation will help to build the evidence base for this assessment.
Given the importance of the civil society’s participation in this exercise and the essential role conferred to its involvement by the EU Drugs Strategy itself, we kindly invite you to contribute to the consultation by filling in this online questionnaire.
Furthermore, we would very much appreciate if you could share this message with other stakeholders active at European, national or local level that may be interested in the topic.
The public consultation will be open until 9 May 2016.
Guidance note for EURAD stakeholders and affiliates
Should you wish further information on the Evaluation of the EU Drugs Strategy and the EU Action Plan , do not hesitate to contact Fay Watson, Secretary General of EURAD, who is leading the consultation input from EURAD.
A guidance note has been created for EURAD stakeholders and affiliates. To receive this, please e-mail email@example.com